Published March 2022 | Version v1
Journal article

Therapeutic Intervention Using a Smad7-Based Tat Protein to Treat Radiation-Induced Oral Mucositis

  • 1. Department of Environmental and Radiological Health Sciences, Colorado State University, Fort Collins (United States)
  • 2. Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora (United States)
  • 3. Allander Biotechnologies, LLC, Aurora (United States)

Description

Recent studies reported therapeutic effects of Smad7 on oral mucositis in mice without compromising radiation therapy–induced cancer cell killing in neighboring oral cancer. This study aims to assess whether a Smad7-based biologic can treat oral mucositis in a clinically relevant setting by establishing an oral mucositis model in dogs and analyzing molecular targets.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.ijrobp.2021.09.039

Additional details

Identifiers

DOI
10.1016/j.ijrobp.2021.09.039;
PII
S0360301621028431;

Publishing Information

Journal Title
International Journal of Radiation Oncology, Biology and Physics
Journal Volume
112
Journal Issue
3
Journal Page Range
p. 759-770
ISSN
0360-3016
CODEN
IOBPD3

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
53124607
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
CELL KILLING; DOGS; MICE; NEOPLASMS; PROTEINS; RADIOTHERAPY
Descriptors DEC
ANIMALS; DISEASES; MAMMALS; MEDICINE; NUCLEAR MEDICINE; ORGANIC COMPOUNDS; RADIOLOGY; RODENTS; THERAPY; VERTEBRATES

Optional Information

Copyright
Copyright (c) 2021 Elsevier Inc. All rights reserved.